Results 11 to 20 of about 243,161 (291)

Attitudes and Behaviors of Anesthesia Workers in Turkey Towards Drug Labeling: A Questionnaire Study

İstanbul Medical Journal, 2019
Introduction:Standard drug syringe labels can reduce drug errors. In this study, it was aimed to report the attitudes of anesthesia workers (AW) towards labeling, to emphasize the importance of drug labeling in drug errors and to contribute to safe ...
Gamze Küçükosman, Bengü Gülhan Aydın, Hilal Ayoğlu   +2 more
doaj   +2 more sources

Labelling of stock preparations and extemporaneous drugs: National and international legislation and practices [PDF]

Arhiv za farmaciju, 2014
The pharmaceutical industry has provided drug production of uniform quality, safety and efficacy, and the same is necessary for the preparation of stock preparations and extemporaneous drugs.
Vuleta Gordana, Dabović Marija, Đekić Ljiljana   +2 more
doaj   +1 more source

Factors that Facilitate and Hinder the Comprehension of Patient Information Leaflets (PILs): A Brief Scoping Review

Frontiers in Pharmacology, 2021
Introduction: Patient information leaflets (PILs) of medicinal products are informative documents that accompany medicines and explain their components, modes of use, interactions with other medicines, and other relevant issues.
Mariana Medina-Córdoba, Sara Cadavid, Andrés M. Pérez-Acosta, Valentina Amaya-Giraldo   +3 more
doaj   +1 more source

Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States

Frontiers in Pharmacology, 2023
Pharmacogenomics, which is defined as the study of changes in the properties of DNA and RNA associated with drug response, enables the prediction of the efficacy and adverse effects of drugs based on patients’ specific genetic mutations. For the safe and
Mijin Lee, Ji Min Han, Jaeyeon Lee, Ju Young Oh, Jung Sun Kim, Hye Sun Gwak, Kyung Hee Choi   +6 more
doaj   +1 more source

Pharmacists’ Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation

Pharmacy, 2022
The “breakthrough therapy” designation (BTD) is a recent mechanism implemented by the United States Food and Drug Administration (FDA) to expedite access to drugs that address unmet needs.
Megan C. Herink, Kirbee Johnston, Kristin Breninger, Erin Wu, Adriane N. Irwin   +4 more
doaj   +1 more source

Labelling Drugs [PDF]

BMJ, 1966
  +12 more sources

Community Labeling: Former Drug Convicts Become Drug Convicts Again

Digital Press Social Sciences and Humanities, 2023
This research was motivated by the discovery of information about ex-drug convicts at Class IIB Padang prison who returned to drug convicts after repeating the same incident.
Mira Hasti Hasmira, Suhai Ratu Rahmi
doaj   +1 more source

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015

Frontiers in Pharmacology, 2019
Background: Recent studies in several countries show a significant decrease in the consumption of osteoporosis drugs from a peak around 2009, mainly attributed to bisphosphonate safety warnings issued by regulatory agencies on jaw osteonecrosis, atypical
Isabel Hurtado-Navarro, Isabel Hurtado-Navarro, Aníbal García-Sempere, Aníbal García-Sempere, Clara Rodríguez-Bernal, Clara Rodríguez-Bernal, José Sanfélix-Genovés, José Sanfélix-Genovés, Salvador Peiró, Salvador Peiró, Gabriel Sanfélix-Gimeno, Gabriel Sanfélix-Gimeno   +11 more
doaj   +1 more source

Do asian patients require only half of the clozapine dose prescribed for caucasians? A critical overview

Indian Journal of Psychological Medicine, 2020
Since 1997, studies have found that Asians need lower clozapine doses than Caucasians. Caucasians with average clozapine metabolism may need from 300 to 600 mg/day to reach the therapeutic range (350 ng/ml). Thus, serum clozapine concentration-to-dose (C/
Jose de Leon, Anto P Rajkumar, Arun R Kaithi, Georgios Schoretsanitis, John M Kane, Chuan-Yue Wang, Yi-Lang Tang, Shih-Ku Lin, Kyung Sue Hong, Saeed Farooq, Chee H Ng, Can-Jun Ruan, Chittaranjan Andrade   +12 more
doaj   +1 more source

Cardiovascular Drug Labeling: Do They Have Information on Necessary Precautions for Older People? [PDF]

Geriatrics, Gerontology and Aging
OBJECTIVE: To analyze the existence of information on drug labeling intended for health professionals on the precaution of cardiovascular drugs use in older people.
Lucas Oliveira Marques, Roberta Coutinho Vasconcelos, André Oliveira Baldoni, Ana Cristina Nogueira Rodrigues Pestana, Farah Maria Drumond Chequer   +4 more
doaj   +1 more source